NEW YORK (GenomeWeb News) – Exact Sciences said Tuesday that it has licensed worldwide rights to Hologic's Invader plus and real-time Invader detection chemistries for colorectal screening applications.

Terms of the agreement are not being disclosed by the firms.

The Invader chemistry was developed by Hologic subsidiary Third Wave Technologies, which formerly was run by Exact Sciences' current President and CEO Kevin Conroy, before it was acquired by Hologic for $580 million in July 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.